尼马特利韦+利托那韦治疗COVID-19的有效性和安全性。NiRCoV研究：通信

{"title":"尼马特利韦+利托那韦治疗COVID-19的有效性和安全性。NiRCoV研究：通信","authors":"H. Daungsupawong , V. Wiwanitkit","doi":"10.1016/j.semerg.2025.102485","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 6","pages":"Article 102485"},"PeriodicalIF":0.9000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effectiveness and safety of nirmatrelvir + ritonavir in COVID-19. NiRCoV Study: Correspondence\",\"authors\":\"H. Daungsupawong , V. Wiwanitkit\",\"doi\":\"10.1016/j.semerg.2025.102485\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":53212,\"journal\":{\"name\":\"Medicina de Familia-SEMERGEN\",\"volume\":\"51 6\",\"pages\":\"Article 102485\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2025-03-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicina de Familia-SEMERGEN\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1138359325000383\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PRIMARY HEALTH CARE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina de Familia-SEMERGEN","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1138359325000383","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}